PSD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.029610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.719000E-03
Normal-vs-Stage2
1.281190E-01
Normal-vs-Stage3
8.884200E-02
Normal-vs-Stage4
3.821400E-01
Stage1-vs-Stage2
1.874080E-02
Stage1-vs-Stage3
7.778800E-01
Stage1-vs-Stage4
1.609150E-01
Stage2-vs-Stage3
6.436200E-01
Stage2-vs-Stage4
4.590200E-01
Stage3-vs-Stage4
2.977200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.090980E-01
Normal-vs-AfricanAmerican
1.729010E-01
Normal-vs-Asian
1.800550E-03
Caucasian-vs-AfricanAmerican
9.049000E-01
Caucasian-vs-Asian
1.359970E-02
AfricanAmerican-vs-Asian
2.361800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.283240E-01
Normal-vs-Female
8.179900E-02
Male-vs-Female
9.637200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.035700E-02
Normal-vs-Age(41-60Yrs)
1.722790E-01
Normal-vs-Age(61-80Yrs)
1.146770E-01
Normal-vs-Age(81-100Yrs)
9.220400E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.589000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.323800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.514000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.726370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.542400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.894200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.801730E-02
Normal-vs-Daily Drinker
1.248130E-02
Normal-vs-Weekly Drinker
6.587600E-02
Normal-vs-Occasional Drinker
4.454400E-01
Normal-vs-Social Drinker
5.518000E-01
Non Drinker-vs-Daily Drinker
5.690000E-01
Non Drinker-vs-Weekly Drinker
3.363000E-01
Non Drinker-vs-Occasional Drinker
1.636750E-01
Non Drinker-vs-Social Drinker
1.768170E-01
Daily Drinker-vs-Weekly Drinker
1.703650E-01
Daily Drinker-vs-Occasional Drinker
9.367800E-02
Daily Drinker-vs-Social Drinker
1.116170E-01
Weekly Drinker-vs-Occasional Drinker
4.830200E-01
Weekly Drinker-vs-Social Drinker
4.342400E-01
Occasional Drinker-vs-Social Drinker
8.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.504400E-01
Normal-vs-Grade 2
5.593800E-02
Normal-vs-Grade 3
1.473440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.136960E-03
Grade 1-vs-Grade 3
3.342000E-03
Grade 1-vs-Grade 4
2.504400E-01
Grade 2-vs-Grade 3
6.589800E-01
Grade 2-vs-Grade 4
5.593800E-02
Grade 3-vs-Grade 4
1.473440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.583430E-01
Normal-vs-NonDiabetic
7.833600E-02
Diabetic-vs-NonDiabetic
8.981200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.243800E-02
Normal-vs-NoPancreatitis
1.085770E-01
Pancreatitis-vs-NoPancreatitis
8.215400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.681210E-01
Normal-vs-N1
9.099700E-02
N0-vs-N1
7.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.857000E-01
Normal-vs-TP53-NonMutant
3.678400E-02
TP53-Mutant-vs-TP53-NonMutant
2.558200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
